These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 14662972)

  • 81. [Infections of the respiratory tract with Pseudomonas aeruginosa in cystic fibrosis].
    Winkler U; Wingender J; Jäger KE
    Klin Wochenschr; 1985 Jun; 63(11):490-8. PubMed ID: 3925219
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Multiresistant Pseudomonas aeruginosa in a pediatric cystic fibrosis center: natural history and implications for segregation.
    Davies G; McShane D; Davies JC; Bush A
    Pediatr Pulmonol; 2003 Apr; 35(4):253-6. PubMed ID: 12629620
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Viral-Bacterial Co-infections in the Cystic Fibrosis Respiratory Tract.
    Kiedrowski MR; Bomberger JM
    Front Immunol; 2018; 9():3067. PubMed ID: 30619379
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Pseudomonas aeruginosa in children with cystic fibrosis diagnosed through newborn screening: assessment of clinic exposures and microbial genotypes.
    Hayes D; West SE; Rock MJ; Li Z; Splaingard ML; Farrell PM
    Pediatr Pulmonol; 2010 Jul; 45(7):708-16. PubMed ID: 20575089
    [TBL] [Abstract][Full Text] [Related]  

  • 85. DCTN4 as a modifier of chronic Pseudomonas aeruginosa infection in cystic fibrosis.
    Viel M; Hubert D; Burgel PR; Génin E; Honoré I; Martinez B; Gaitch N; Chapron J; Kanaan R; Dusser D; Girodon E; Bienvenu T
    Clin Respir J; 2016 Nov; 10(6):777-783. PubMed ID: 25763772
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Acquisition of Pseudomonas aeruginosa in children with cystic fibrosis.
    Farrell PM; Shen G; Splaingard M; Colby CE; Laxova A; Kosorok MR; Rock MJ; Mischler EH
    Pediatrics; 1997 Nov; 100(5):E2. PubMed ID: 9346996
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Marker genes for the metabolic adaptation of Pseudomonas aeruginosa to the hypoxic cystic fibrosis lung environment.
    Eichner A; Günther N; Arnold M; Schobert M; Heesemann J; Hogardt M
    Int J Med Microbiol; 2014 Nov; 304(8):1050-61. PubMed ID: 25130702
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience.
    Hansen CR; Pressler T; Høiby N
    J Cyst Fibros; 2008 Nov; 7(6):523-30. PubMed ID: 18693078
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Increased treatment requirements of patients with cystic fibrosis who harbour a highly transmissible strain of Pseudomonas aeruginosa.
    Jones AM; Dodd ME; Doherty CJ; Govan JR; Webb AK
    Thorax; 2002 Nov; 57(11):924-5. PubMed ID: 12403871
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Segregation is good for patients with cystic fibrosis.
    Conway S
    J R Soc Med; 2008 Jul; 101 Suppl 1(Suppl 1):S31-5. PubMed ID: 18607016
    [No Abstract]   [Full Text] [Related]  

  • 91. Th17 associated cytokines in sputum samples from patients with cystic fibrosis.
    Oshalim M; Johansson E; Rabe H; Gilljam M; Lindblad A; Jönsson B
    Pathog Dis; 2020 Sep; 78(6):. PubMed ID: 32876666
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Toll-like receptors in the host defense against Pseudomonas aeruginosa respiratory infection and cystic fibrosis.
    McIsaac SM; Stadnyk AW; Lin TJ
    J Leukoc Biol; 2012 Nov; 92(5):977-85. PubMed ID: 22892106
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Transmission of Pseudomonas aeruginosa in children with cystic fibrosis attending summer camps in The Netherlands.
    Brimicombe RW; Dijkshoorn L; van der Reijden TJ; Kardoes I; Pitt TL; van den Broek PJ; Heijerman HG
    J Cyst Fibros; 2008 Jan; 7(1):30-6. PubMed ID: 17532271
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Segregation and use of nonshared care settings reduce the risk of multiresistant P. aeruginosa infection. Re: Davies et al., "Multiresistant Pseudomonas aeruginosa in a pediatric cystic fibrosis center: natural history and implications for segregation," Pediatr Pulmonol 2003;35:253-256.
    Festini F; Ballarin S; Loganes C
    Pediatr Pulmonol; 2003 Aug; 36(2):171; author reply 172. PubMed ID: 12833499
    [No Abstract]   [Full Text] [Related]  

  • 95. Antibiotic therapy in cystic fibrosis. Evaluation of efficacy.
    Levy J
    Chest; 1988 Aug; 94(2 Suppl):150S-156S. PubMed ID: 3135160
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Type III apparatus of Pseudomonas aeruginosa as a tool to diagnose pulmonary infection in cystic fibrosis patients.
    Cruz AC; Neves BC; Higa LY; Folescu T; Marques EA; Milagres LG
    APMIS; 2012 Aug; 120(8):622-7. PubMed ID: 22779684
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Transmission of Pseudomonas aeruginosa epidemic strain from a patient with cystic fibrosis to a pet cat.
    Mohan K; Fothergill JL; Storrar J; Ledson MJ; Winstanley C; Walshaw MJ
    Thorax; 2008 Sep; 63(9):839-40. PubMed ID: 18728207
    [TBL] [Abstract][Full Text] [Related]  

  • 98.
    Hilliam Y; Moore MP; Lamont IL; Bilton D; Haworth CS; Foweraker J; Walshaw MJ; Williams D; Fothergill JL; De Soyza A; Winstanley C
    Eur Respir J; 2017 Apr; 49(4):. PubMed ID: 28446558
    [TBL] [Abstract][Full Text] [Related]  

  • 99. [Improving the management of chronic
    She DY
    Zhonghua Jie He He Hu Xi Za Zhi; 2022 Aug; 45(8):733-735. PubMed ID: 35927042
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Perception of first respiratory infection with Pseudomonas aeruginosa by people with cystic fibrosis and those close to them: an online qualitative study.
    Palser SC; Rayner OC; Leighton PA; Smyth AR
    BMJ Open; 2016 Dec; 6(12):e012303. PubMed ID: 28031208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.